The opening price for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was $50.07 and the volume amounted to 3.17 million shares which compares with the average volume of 2.38 million shares. The company stock experienced a 0.72% move to arrive at $50.31.DENTSPLY SIRONA Inc. (XRAY) Analyst Opinion
DENTSPLY SIRONA Inc. has a consensus outperform rating from 16 Wall Street analysts, and the number of shares currently sold short amount to at least 1.62% of shares outstanding. The stock sank -10.26% last month and is down -23.58 this year. Wall Street is only getting more bullish on the stock, with 10 of analysts who cover XRAY having a buy-equivalent rating. Analysts have placed a $68.57 price target on DENTSPLY SIRONA Inc., suggesting a 36.29% gain from recent close. It’s currently trading about -27.07% below its 52-week high.
DENTSPLY SIRONA Inc. (XRAY) surprised the stock market in its last reported earnings when it earned $0.82 a piece versus the consensus-estimated $0.81. Its revenue totaled $1.06 billion up 4.61% from the previous quarter.DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Intraday View
This stock (XRAY) is ahead of its 52-week low with 0.9%. Its last month’s stock price volatility remained 3.22% which for the week stands at 2.73%. The share price has moved backward from its 20 days moving average, trading at a distance of -8.61% and stays -12.68% away from its 50 days moving average. Over the last five days, shares have faced -4.46% losses and now is down -17.45% since hitting its 200-day moving average of $61.05. DENTSPLY SIRONA Inc. (XRAY) has made its way to a 12-month decline of -20.07%.
Turning to Okta, Inc. (NASDAQ:OKTA), its shares were trading at $39.85 a gain of $1.58, on the trading floor. The stock, after opening at $38.37, touched a high of $40.06 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.1. Okta, Inc. has 3 buy ratings, 3 holds and 0 sells even after the stock tumbled -7.08% from its high of $42.88 to a $3.9 billion market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 2 to 2 during a month. Analysts set a 12-month price target of $42.43 a share. The target implies a 6.47% spike from where the shares are currently trading. Also, the current price highlights a discount of 25.47% to analysts’ high consensus price target.
The counter witnessed a trading volume of 2.4 million shares versus an average volume of 1.95 million shares during last trading session. Its last month’s stock price volatility remained 4.82% which for the week approaches 5.09%. The lowest price the stock reached in the last trading day was $37.29 and compares with the $21.52 52-week low. The stock recovered 85.18% since its low point and has performed 55.6% year-to-date.